Oral candidosis – Clinical challenges of a biofilm disease
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
This review summarizes the impact of biofilms in oral candidosis with special emphasis on medically compromised patients. The concept of oral candidosis as a mixed candidal-bacterial biofilm infection has changed our understanding of its epidemiology and diagnosis as well as approach to its treatment. Candida albicans is the most common causative agent of oral candidosis although Candida species other than C. albicans are often seen in medically compromised patients with a history of multiple courses of azole antifungals. Although C. albicans is usually susceptible to all commonly used antifungals when tested in vitro, their biofilm form are highly resistant to most antifungals. Therefore, treatment consists of mechanical destruction of the biofilm in combination with topical drugs. Azole antifungals should be avoided for patients suffering from recurrent oral yeast infections due to a risk of selection and enrichment of resistant strains within the biofilm. Oral candidosis can also be a symptom of an undiagnosed or poorly controlled systemic disease such as HIV infection or diabetes. If the response to appropriate treatment is poor, other causes of oral mucositis should be excluded. Oral candidosis arises from the patient's mixed candidal-bacterial biofilm, i.e., dental plaque, whereby good self-care is important for successful therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167 · cited 1×
“It is estimated that up to 80% of all microorganisms in the environment exist in surface attached (sessile) biofilm communities and over 65% of human microbial infections involve biofilms in one way or another (Costerton et al., 1999; Donlan & Costerton, 2002; Rasmussen & Givskov, 2006).”
BackgroundBiofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644
Guidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440 · cited 1×
“Itraconazole is absorbed best from the oral solution (Pappas et al., 2004).”
BackgroundMorrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286
Candida albicans Secreted Aspartyl Proteinases in Virulence and Pathogenesis
Naglik, J. R., Challacombe, S. J., & Hube, B. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.3.400-428.2003 · Cited by 1,179 · cited 1×
“In addition, the release of extracellular proteolytic and lipolytic enzymes contributes to their pathogenicity (Naglik et al., 2003; Naglik et al., 2008).”
BackgroundGarey, K. W., Rege, M., Pai, M. P., Mingo, D. E., Suda, K. J., Turpin, R. S., & Bearden, D. T. (2006) · Clinical Infectious Diseases · doi:10.1086/504810 · Cited by 1,171 · cited 1×
“A delay in the initiation of effective antifungal therapy increases mortality in a candidaemia (Morrell et al., 2005; Garey et al., 2006).”
BackgroundCharacterization of the oral fungal microbiome (mycobiome) in healthy individuals
Ghannoum, M. A., Jurevic, R. J., Mukherjee, P. K., Cui, F., Sikaroodi, M., Naqvi, A., & Gillevet, P. M. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000713 · Cited by 1,150 · cited 1×
“For most individuals yeasts are a part of the oral microbiota and only cause infection if an opportunity arises (Samaranayake et al., 2009; Ghannoum et al., 2010).”
BackgroundPierce, C. G., Uppuluri, P., Tristan, A. R., Wormley, F. L., Mowat, E., Ramage, G., & Lopez-Ribot, J. L. (2008) · Nature Protocols · doi:10.1038/nprot.2008.141 · Cited by 1,041 · cited 2×
“Recent advances in this have been made to produce a standardized method of testing for yeast biofilms (Ramage et al, 2001a; Pierce et al, 2008).”
BackgroundMethodSelf-citationStandardized Method for In Vitro Antifungal Susceptibility Testing of Candida albicans Biofilms
Ramage, G., Vande Walle, K., Wickes, B. L., & López-Ribot, J. L. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2475-2479.2001 · Cited by 753
Self-citationCandida biofilms on implanted biomaterials: a clinically significant problem
Ramage, G., MartÃnez, J. P., & López-Ribot, J. L. (2006) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2006.00117.x · Cited by 575 · cited 3×
“…such as teeth, tooth fillings and dentures, orthodontic appliances, tongue jewellery and an endotracheal tube present in the oral cavity may serve as a yeast reservoir, and a potential source of infection if not thoroughly and regularly cleaned (Ramage et al., 2006; Coulthwaite & Verran, 2007).”
BackgroundSelf-citationDenture stomatitis: a role for Candida biofilms
Ramage, G., Tomsett, K., Wickes, B. L., López-Ribot, J. L., & Redding, S. W. (2004) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2003.04.002 · Cited by 489 · cited 1×
“For example, for localized areas of inflammation or suspected reservoirs of infection, the oral swab or imprint culture is the preferred sampling technique (Ramage et al., 2004; Rautemaa et al., 2006; Rusanen et al., 2009).”
BackgroundSelf-citationOur Current Understanding of Fungal Biofilms
Ramage, G., Mowat, E., Jones, B., Williams, C., & Lopez-Ribot, J. (2009) · Critical Reviews in Microbiology · doi:10.3109/10408410903241436 · Cited by 483 · cited 1×
“There are a number of virulence attributes of Candida that contribute to the pathogenesis of oral candidosis, including adhesion to host surfaces, morphological transformation, and extracellular enzyme production; characteristics that are central to biofilm formation (Ramage et al., 2009).”
BackgroundSelf-citationSalminen, M. K., Rautelin, H., Tynkkynen, S., Poussa, T., Saxelin, M., Valtonen, V., & Jarvinen, A. (2004) · Clinical Infectious Diseases · doi:10.1086/380455 · Cited by 426 · cited 1×
“In immunocompromised patients, however, the damaged mucosa may act as a portal of entry for the probiotic micro-organism and result in bacteraemia and sepsis (Salminen et al., 2004).”
BackgroundIn Vitro Activity of Caspofungin against Candida albicans Biofilms
Bachmann, S. P., VandeWalle, K., Ramage, G., Patterson, T. F., Wickes, B. L., Graybill, J. R., & López-Ribot, J. L. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3591-3596.2002 · Cited by 288
Self-citationNaglik, J. R., Moyes, D., Makwana, J., Kanzaria, P., Tsichlaki, E., Weindl, G., Tappuni, A. R., Rodgers, C. A., Woodman, A. J., Challacombe, S. J., et al. (2008) · Microbiology · doi:10.1099/mic.0.2008/022293-0 · Cited by 253 · cited 1×
“In addition, the release of extracellular proteolytic and lipolytic enzymes contributes to their pathogenicity (Naglik et al., 2003; Naglik et al., 2008).”
BackgroundVediyappan, G., Rossignol, T., & d'Enfert, C. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01638-09 · Cited by 183 · cited 1×
“It was also recently demonstrated that polyenes bind to extrapolymeric material, limiting access to cell membranes (Vediyappan et al., 2010).”
BackgroundAntifungal Combinations against Candida albicans Biofilms In Vitro
Bachmann, S. P., Ramage, G., VandeWalle, K., Patterson, T. F., Wickes, B. L., & López-Ribot, J. L. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3657-3659.2003 · Cited by 89 · cited 1×
“Still, certain antifungal agents have been shown to be efficacious against yeast biofilms, particularly liposomal amphotericin B formulations and the echinocandins (Bachmann et al., 2002; Kuhn et al., 2002; Ramage et al., 2002b; Bachmann et al., 2003).”
BackgroundSelf-citationDavis, S. L., Vazquez, J. A., & Mckinnon, P. S. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1h516 · Cited by 71
Siikala, E., Rautemaa, R., Richardson, M., Saxen, H., Bowyer, P., & Sanglard, D. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq354 · Cited by 66 · cited 1×
“When using fluconazole and other drugs of the azole group it should be remembered that colonization with resistant strains seems to be fairly permanent even though the selection pressure would no longer favor them (Rautemaa et al., 2007b; Siikala et al., 2010).”
Background
Cited by
Sardi, J. C. O., Scorzoni, L., Bernardi, T., Fusco-Almeida, A. M., & Mendes Giannini, M. J. S. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.045054-0 · Cited by 1,184
de Oliveira Santos, G. C., Vasconcelos, C. C., Lopes, A. J. O., de Sousa Cartágenes, M. D. S., Filho, A. K. D. B., do Nascimento, F. R. F., Ramos, R. M., Pires, E. R. R. B., de Andrade, M. S., Rocha, F. M. G., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01351 · Cited by 350
Clinical Appearance of Oral Candida Infection and Therapeutic Strategies
Patil, S., Rao, R. S., Majumdar, B., & Anil, S. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01391 · Cited by 324
Candida Species Biofilms’ Antifungal Resistance
Silva, S., Rodrigues, C., Araújo, D., Rodrigues, M., & Henriques, M. (2017) · Journal of Fungi · doi:10.3390/jof3010008 · Cited by 302
Graham, C. E., Cruz, M. R., Garsin, D. A., & Lorenz, M. C. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620432114 · Cited by 239
“Additionally, EntV dramatically reduced invasion and inflammation in a murine model of oropharyngeal candidiasis (OPC), a biofilm-related infection that is common in immunocompromised patients (18).”
Background
Metadata
- Authors
- Rautemaa, R., & Ramage, G.
- Venue
- Critical Reviews in Microbiology
- Publisher
- Informa UK Limited
- Published
- 2011-07-21
- Volume
- 37
- Issue
- 4
- Pages
- 328-336
- ISSN
- 1040-841X (ISSN-L)
- 1549-7828
- OpenAlex
- W1978772553
- Cited by
- 188
- References
- 19
- FWCI
- 8.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.